NAM Use for Regulatory Application

El lugar de los modelos computacionales en la regulación de sustancias químicas: experiencias en América Latina

Jueves, 7 de mayo de 2026
[Thursday, May 7, 2026]
11 am ET / 12:00 BRT / 15:00 UTC

PRESENTADOR

Anax Falcão de Oliveira, PhD, DABT

Descripción:

En este seminario web en español, el Dr. Falcão discutirá el auge de los enfoques de toxicología computacional en la regulación química y analizará los diversos contextos regulatorios en América Latina donde estos modelos pueden respaldar las evaluaciones de seguridad química en diversos sectores industriales. Obtenga más información en www.pcrm.org/NURAenEspanol.

In this Spanish-language webinar, Dr. Falcão will discuss the rise of computational toxicology approaches in chemical regulation and analyze the various regulatory contexts in Latin America where these models can support chemical safety assessments in diverse industrial sectors. Complete details are available at www.pcrm.org/NURAenEspanol.

REGÍSTRESE

Xeno-Free Reagents in Chemical Assessments

Tuesday, June 2, 2026
10:00 am to 12:15 pm ET / 14:00 to 16:15 UTC

Researchers commonly rely on animal-based reagents for their work; from biomedical science to toxicology—even human-based in vitro assays—scientists regularly use them in their protocols. However, these reagents introduce unnecessary variation within data that animal-free alternatives can avoid. In this webinar, experts in the field will discuss some of the problems with animal-based components and highlight the advantages of xeno-free reagents. Attendees will also hear from experts who are successfully using alternatives to animal-based reagents to improve the reliability of their data.

Complete details are available at www.pcrm.org/ReagentTraining.

REGISTER

NAM Spotlight: Reimagining Carcinogenicity Assessment Beyond the Rodent Bioassay: Next-Generation Carcinogenicity Risk Assessment with Kaptis

Wednesday, June 10, 2026
10:00-11:00 am ET / 14:00-15:00 UTC

Featuring:

Alex Cayley, PhD, Principal Scientist at Lhasa Limited

Pavlos Dimitriou, MSc, Business Partnerships Manager at Lhasa Limited

For decades, carcinogenicity assessments have relied on traditional animal-based approaches that are increasingly recognised as resource-intensive and poorly predictive of human outcomes. Building from successful use cases and worked examples, this webinar will illustrate how next generation carcinogenicity assessment approaches can be implemented in practice and will feature a demonstration of Kaptis, a Lhasa Limited AOP-driven decision support solution.

Complete details are available at www.pcrm.org/NAMSpotlight.

REGISTER

NURA en Español: Avances integrados en la evaluación regulatoria moderna: datos, métodos y enfoques innovadores

Jueves, 2 de julio de 2026
[Thursday, July 2, 2026]
10:00-11:00 am ET / 14:00-15:00 UTC

PRESENTADORA

Ester Carregal Romero, PhD

Descripción:

Esta ponencia en español ofrece una visión global de los principales elementos que están configurando la evaluación regulatoria contemporánea a nivel internacional. Aborda el papel de las Guías de Ensayo de la OCDE y su evolución para apoyar la transición hacia metodologías sin animales, así como los principios clave para la gestión, estructuración y calidad de los datos regulatorios, con especial atención a las Plantillas Armonizadas de la OCDE. Obtenga más información en www.pcrm.org/NURAenEspanol.

This Spanish-language presentation offers a comprehensive overview of the key elements shaping contemporary regulatory assessment at the international level. It addresses the role of OECD Test Guidelines and their evolution to support the transition toward animal-free methodologies, as well as the key principles for the management, structuring, and quality of regulatory data, with particular emphasis on OECD Harmonized Templates. Complete details are available at www.pcrm.org/NURAenEspanol.

REGÍSTRESE

NURA is developing several new in-person and virtual training opportunities, including:

• NAMs for Sunscreens
• A Hands-on QSAR Training
• Validation of NAMs

Join our mailing list to get updates on our latest learning opportunities. You can also use the form to provide feedback and suggest training topics. Alternatively, you can email us with your comments and suggestions at nura [at] pcrm.org. 

We would like to feature your human-based nonanimal approach in a webinar. 

You will have the opportunity to present your method to a diverse professional audience from industry, government, NGOs, and academia, followed by an audience-led Q&A session. We are looking for:

• Case studies of NAMs that have been submitted in FDA applications.
• NAMs currently being used in regulatory applications or those that have the potential to replace animal use in regulatory applications.

Please submit your presentation title and abstract or speaker suggestion to nura [at] pcrm.org. 

Connect With Us